ATAI Life Sciences N.V [NASDAQ: ATAI] price surged by 23.74 percent to reach at $2159997.81.
A sum of 51392639 shares traded at recent session while its average daily volume was at 2.16M shares. ATAI Life Sciences N.V shares reached a high of $2.895 and dropped to a low of $2.36 until finishing in the latest session at $2160000.0.
The one-year ATAI stock forecast points to a potential downside of -23478160.87. The average equity rating for ATAI stock is currently 1.00, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on ATAI Life Sciences N.V [ATAI]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ATAI shares is $9.20 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ATAI stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
H.C. Wainwright have made an estimate for ATAI Life Sciences N.V shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 18, 2024. The new note on the price target was released on April 03, 2024, representing the official price target for ATAI Life Sciences N.V stock. Previously, the target price had yet another raise to $18, while Loop Capital analysts kept a Buy rating on ATAI stock.
The Price to Book ratio for the last quarter was 3.56, with the Price to Cash per share for the same quarter was set at 0.54.
ATAI Stock Performance Analysis:
ATAI Life Sciences N.V [ATAI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 28.44. With this latest performance, ATAI shares gained by 17.32% in over the last four-week period, additionally plugging by 116.80% over the last 6 months – not to mention a rise of 103.76% in the past year of trading.
Insight into ATAI Life Sciences N.V Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and ATAI Life Sciences N.V [ATAI] shares currently have an operating margin of -31987.01% and a Gross Margin at -5.44%. ATAI Life Sciences N.V’s Net Margin is presently recorded at -38852.87%.
Return on Equity for this stock declined to -50.86%, with Return on Assets sitting at -50.86%.
ATAI Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ATAI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for ATAI Life Sciences N.V go to 30.52%.
ATAI Life Sciences N.V [ATAI] Institutonal Ownership Details
There are presently around $33.40%, or 36.39%% of ATAI stock, in the hands of institutional investors. The top three institutional holders of ATAI stocks are: WALLEYE CAPITAL LLC with ownership of 2.76 million shares, which is approximately 1.7226%. MORGAN STANLEY, holding 2.72 million shares of the stock with an approximate value of $$3.62 million in ATAI stocks shares; and MORGAN STANLEY, currently with $$1.74 million in ATAI stock with ownership which is approximately 0.8148%.
